STOCK TITAN

EIDP: Corteva completes Vylor seed business spin-off

Board and officer changes took effect alongside the separation, including Luke Kissam’s appointment as Corteva’s chief executive officer and director.

(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
8-K

Rhea-AI Filing Summary

EIDP, Inc. reported that Corteva, Inc. completed the separation of its seed operating segment into Vylor Inc., an independent, publicly traded company, at 12:03 a.m. New York City time on October 1, 2026. The separation created two independent, publicly traded companies.

At the same effective time, Charles V. Magro, Kerry J. Preete, Marcos M. Lutz and Karen H. Grimes resigned from Corteva’s board, and Luther (“Luke”) Kissam was appointed a director. Corteva’s officer changes included the resignations of Magro, David P. Johnson, Samuel R. Eathington and Judd M. O’Connor, and the appointments of Kissam as chief executive officer, Jeff Rudolph as chief financial officer, Brook Cunningham as chief commercial officer and Ralph Ford as chief integrated operations officer. The board resignations were in connection with the separation and, as stated, did not result from disagreements over Corteva’s operations, policies or practices.

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Separation effective time 12:03 a.m. New York City time October 1, 2026
Common stock par value $0.01 per share Corteva, Inc.; trading symbol CTVA
Preferred stock series designation $3.50 Series Preferred Stock EIDP, Inc.; trading symbol CTAPrA
Preferred stock series designation $4.50 Series Preferred Stock EIDP, Inc.; trading symbol CTAPrB
Effective Time technical
"at 12:03 a.m., New York City time ... (the “Effective Time”)"
The exact clock time when a regulatory filing, approval, or corporate action formally becomes legally active; from that moment the change is binding and can be acted on. Investors care because the effective time marks when ownership, rights, trading rules, or new securities take effect — like a light switch turning on a contract or transaction — which determines when risks, benefits and market reactions begin.
Separation technical
"through the separation (“Separation”)"
Item 404(a) of Regulation S-K regulatory
"required to be disclosed pursuant to Item 404(a) of Regulation S-K"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Corteva separate in the CTA report?

Corteva separated its seed operating segment into Vylor Inc., an independent, publicly traded company, at 12:03 a.m. New York City time on October 1, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
0001755672false0001755672ck0001755672:EIDPMember2026-10-012026-10-010001755672dei:OtherAddressMember2026-10-012026-10-010001755672ck0001755672:EIDPMemberck0001755672:A4.50SeriesPreferredStockMember2026-10-012026-10-0100017556722026-10-012026-10-010001755672ck0001755672:EIDPMemberck0001755672:A3.50SeriesPreferredStockMember2026-10-012026-10-010001755672us-gaap:CommonStockMember2026-10-012026-10-01

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF

THE SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of Earliest Event Reported): October 1, 2026

Corteva, Inc.

EIDP, Inc.

(Exact Name of Registrant as Specified in Its Charter)

 

Delaware

001-38710

82-4979096

Delaware

 

001-00815

 

 

51-0014090

 

(State or other jurisdiction

(Commission

(I.R.S. Employer

of Incorporation)

File Number)

Identification No.)

 

9330 Zionsville Road, Indianapolis, Indiana

46268

1000 N. West Street, Suite 800, Wilmington, Delaware

19801

(Address of principal executive offices)

(Zip Code)

 

(833) 267-8382

(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Registrant

 

Title of each class

 

Trading Symbol(s)

 

Name of each exchange on which registered

Corteva, Inc.

 

Common Stock, par value $0.01

CTVA

New York Stock Exchange

EIDP, Inc.

 

$3.50 Series Preferred Stock

 

 

CTAPrA

 

 

New York Stock Exchange

EIDP, Inc.

 

$4.50 Series Preferred Stock

 

 

CTAPrB

 

 

New York Stock Exchange

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

 

 

 


 

Introductory Note.

At 12:03 a.m., New York City time, on October 1, 2026 (the “Effective Time”), Corteva, Inc. (the “Company”) completed its previously announced separation into two independent, publicly traded companies through the separation (“Separation”) of the Company’s seed operating segment into an independent, publicly traded company, Vylor Inc. (“Vylor”).

 

Item 5.02

Departure of Directors and Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Appointment and Resignation of Directors

 

Appointment and Resignation of Directors

In connection with the Separation, Charles V. Magro resigned from his position as a member of the Company’s Board of Directors (the “Board”) effective as of the Effective Time. Additionally, each of Kerry J. Preete, Marcos M. Lutz and Karen H. Grimes resigned from their respective positions as members of the Board, as well as their respective positions as members of various Committees thereof, in each case, effective as of the Effective Time.

As of immediately prior to the Effective Time, Ms. Grimes and Messrs. Lutz and Preete served on the following Committees:

•
Ms. Grimes served on the Audit Committee;
•
Messrs. Lutz and Preete and Ms. Grimes served on the People and Compensation Committee; and
•
Messrs. Lutz and Preete served on the Science and Innovation Committee.

Each of Messrs. Lutz’s, Magro’s and Preete’s and Ms. Grimes’ decision to resign from the Board is in connection with the Separation, and is not the result of any disagreement relating to the Company’s operations, policies or practices.

In connection with the Separation, the Board appointed Luther (“Luke”) Kissam as a director of the Company effective as of the Effective Time.

Effective as of the Effective Time, the Committees of the Board were comprised of the following members:

 

Committee

Members

Audit Committee

Patrick J. Ward (Chair)

Gregory R. Page

Nayaki R. Nayyar

Christopher J. Policinski

Governance and Compliance Committee

Janet P. Giesselman (Chair)

Gregory R. Page

Klaus A. Engel, Ph.D.

Christopher J. Policinski

People and Compensation Committee

David C. Everitt (Chair)

Jean-Marc Gilson

Nayaki R. Nayyar

Patrick J. Ward

Science and Innovation Committee

Klaus A. Engel, Ph.D. (Chair)

David C. Everitt

Janet P. Giesselman

Jean-Marc Gilson

 

None of the foregoing directors is a party to any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K. There are no arrangements or understandings between any of such directors and any other person or the Company pursuant to which such directors were appointed to serve in his or her respective role.

 


 

Appointment and Resignation of Officers

As previously disclosed in the Company’s Current Report on Form 8-K filed with the SEC on April 14, 2026 (the “April 8-K”), in connection with the Separation, each of Mr. Magro, David P. Johnson, Samuel R. Eathington, Ph.D. and Judd M. O’Connor resigned from their respective positions as officers of the Company, effective as of the Effective Time.

As previously disclosed in the April 8-K, in connection with the Separation, (i) Mr. Kissam was appointed as Chief Executive Officer of the Company, (ii) Jeff Rudolph was appointed as Chief Financial Officer of the Company, (iii) Brook Cunningham was appointed as Chief Commercial Officer of the Company and (iv) Ralph Ford was appointed as Chief Integrated Operations Officer of the Company, in each case, effective as of the Effective Time.

Biographical information for each of Mr. Kissam, Mr. Rudolph, Ms. Cunningham and Mr. Ford and a description of Mr. Kissam’s employment agreement were previously reported in the April 8-K and are incorporated herein by reference.

None of Messrs. Kissam, Rudolph and Ford or Ms. Cunningham has any family relationship with any director or executive officer of the Company, and none is a party to any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K. There are no arrangements or understandings between any of them and any other person pursuant to which he or she was appointed.

 

 

 


 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, each registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

CORTEVA, INC.

 

 

 

 

 

Date: October 7, 2026

 

By:

/s/Jeff Rudolph

 

 

 

Name: Jeff Rudolph

 

 

 

Title: Chief Financial Officer

 

 

 

 

 

 

 

 

 

 

 

 

EIDP, INC.

Date: October 7, 2026

 

By:

/s/ Jeff Rudolph

 

 

 

Name: Jeff Rudolph

 

 

 

Title: Chief Financial Officer

 

 


Filing Exhibits & Attachments

1 document

Keep reading